QUOIN PHARMACEUTICALS LT-ADR (QNRX) Stock Cash Flow
NASDAQ:QNRX - Nasdaq - US74907L4095 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.45M | -8.96M | -8.69M | -9.38M | -21.46M | |||
| Depreciation Amortization | 100.00K | 100.00K | 103.70K | 104.00K | 104.00K | |||
| Change In Working Capital | 239.00K | -2.10K | 95.50K | 619.70K | 1.33M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 393.60K | |||
| Other non cash items | 1.09M | 1.01M | 623.00K | 177.00K | 14.31M | |||
| OPERATING CASH FLOW | -9.02M | -7.86M | -7.86M | -8.48M | -5.72M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | -250.00K | -625.00K | |||
| Other Investing Activity | 5.35M | -1.89M | 2.19M | -9.90M | N/A | |||
| INVESTING CASH FLOW | 5.35M | -1.89M | 2.19M | -10.15M | -625.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -600.00K | -600.00K | -600.00K | -911.70K | 3.31M | |||
| Stock Issued/Repurchased | 6.26M | 11.57M | 5.85M | N/A | N/A | |||
| Other Financing Activity | N/A | N/A | -32.60K | 14.92M | 10.19M | |||
| FINANCING CASH FLOW | 5.66M | 10.97M | 5.22M | 14.01M | 13.50M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 1.99M | 1.22M | -459.40K | -4.62M | 7.16M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -9.02M | -7.86M | -7.86M | -8.48M | -5.72M | |||
| Capital Expenditure | N/A | N/A | N/A | -250.00K | -625.00K | |||
| FREE CASH FLOW | -9.02M | -7.86M | -7.86M | -8.73M | -6.35M | |||
All data in USD